(continued)
- FDA Approves New Treatment for Rare Lipid Storage Disease
- FDA OKs First Fast-Acting Insulin Biosimilar for Diabetes
- FDA OKs Vaccine for Mosquito-Borne Chikungunya
- FDA Approves New Drug for Rare Joint Tumor
- FDA Approves 5-in-1 Vaccine Against Meningococcal Disease
- FDA OKs Triple Combo for Advanced Large B-Cell Lymphoma
- FDA Approves New Treatment for NF1-Related Tumors
- FDA OKs New Antibiotic Combo for Serious Abdominal Infections
- FDA OKs Implantable Treatment for Diabetic Macular Edema
- FDA OKs New Wearable Infusion Device for Parkinson’s
- FDA Approves New Drug Combination for Mantle Cell Lymphoma
- FDA Approves New Non-Opioid Pain Treatment
- FDA OKs Ozempic for Kidney Disease in Diabetes Patients
- FDA Approves Drug for Hard-to-Treat Breast Cancer
- FDA Approves New Prep Regimen for Bone Marrow Transplant
- FDA Approves New Treatment for Advanced Breast Cancer
- FDA Approves Omvoh for Crohn’s Disease
- FDA Approves Zepbound for Obstructive Sleep Apnea
- FDA OKs First Treatment for Familial Chylomicronemia Syndrome
- FDA Approves New Drug for Kids With Severe Immune Disease
- FDA Approves New Drug for Advanced Lung Cancer
- FDA Approves Nemluvio for Atopic Dermatitis
- FDA Approves Drug for Rare Adrenal Gland Disorder
- FDA Approves New Drug for Advanced Skin Cancer
- FDA Approves Drug for Aggressive Small-Cell Lung Cancer
- FDA Approves New Drug for Lung and Pancreatic Cancers
- FDA Approves New SVT Drug for Critical Care Use
- FDA Approves New Drug for Life-Threatening Heart Condition
- FDA Approves New Targeted Treatment for Biliary Tract Cancer
- FDA Approves Bimzelx for Hidradenitis Suppurativa